Sort
53,477 grants matching “addiction”
Center on Interoceptive Dysregulation in Addiction (CIDIA)
$920,933Martin P Paulus · University Of California, San Diego · P20 · FY2010 · DA
Genetics of Opioid Dependence
$920,699Joel Gelernter · Yale University · R01 · FY2016 · DA
Gene-Environment Interplay in the Development of Drug Abuse, HIV Sexual Risk Beha
$920,637Karl Gordon Hill · University Of Washington · R01 · FY2014 · DA
Implementation of telemedicine and social network driven HIV service uptake for comprehensive HIV service integration in rural syringe service programs
$920,447Oluwaseun Falade-Nwulia · Johns Hopkins University · R01 · FY2023 · DA
CLINICAL TRIALS NETWORK, OHIO VALLEY NODE
$920,000University Of Cincinnati · U10 · FY2003 · DA
IMPROVING COMBINED BUPRENORPHINE-BEHAVIORAL TREATMENT
$919,722University Of Vermont &St Agric College · R01 · FY2003 · DA
Targeting undruggable RAS for cancer treatment
$918,610Channing J Der · Univ Of North Carolina Chapel Hill · R35 · FY2020 · CA
Project 2
$918,422Jessica Louise Barrington-Trimis · University Of Southern California · U54 · FY2024 · CA
Identifying Genetic Variants Associated with Opioid Overdose Mortality
$917,989Elliot C Nelson · Washington University · R01 · FY2020 · DA
Quantifying Exposure to Illicit Drugs & Psychosocial Stress in Real Time
$917,979Kenzie Preston · National Institute On Drug Abuse · ZIA · FY2018 · DA
The Neuroproteomics and Neurometabolomics Center on Cell-Cell Signaling
$917,843Jonathan V. Sweedler · University Of Illinois At Urbana-Champaign · P30 · FY2018 · DA
The Neuroproteomics and Neurometabolomics Center on Cell-Cell Signaling
$917,843Jonathan V. Sweedler · University Of Illinois At Urbana-Champaign · P30 · FY2017 · DA
A Double-Blind, Randomized, Controlled Trial of Epidural Conus Medullaris Stimulation to Alleviate Pain and Augment Rehabilitation in Patients with Subacute Thoracic Spinal Cord Injury (SCI)
$917,817Shivanand P Lad · Duke University · UH3 · FY2023 · NS
Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis
$917,731Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Integrating Addiction Treatment and HIV Services into Primary Care Clinics in Ukraine
$917,630Frederick Lewis Altice · Yale University · R01 · FY2018 · DA
Dissemination of Tobacco Tactics versus 1-800-QUIT-NOW for Hospitalized Smokers
$917,504Sonia A Duffy · University Of Michigan At Ann Arbor · U01 · FY2012 · HL
Defining the functions and translational potential of ferroptosis
$916,929Brent R Stockwell · Columbia Univ New York Morningside · R35 · FY2019 · CA
Western States Node of the National Drug Abuse Treatment Clinical Trials Network
$916,590James L. Sorensen · University Of California, San Francisco · U10 · FY2013 · DA
Genetics of Opioid Dependence
$916,048Joel Gelernter · Yale University · R01 · FY2015 · DA
Predictive Smoking Cessation Preclinical Battery
$915,977Taleen G Hanania · Psychogenics, Inc. · R44 · FY2015 · DA
Onsite PTSD Treatment to Improve MOUD Outcomes (OPTIMO): a hybrid Type 1 effectiveness-implementation trial of harm reduction PTSD care at syringe service programs
$915,814Teresa Lopez-Castro · City College Of New York · R61 · FY2023 · DA
Developing and Testing Innovative Care Pathways for Screening and Treatment of OUD/PTSD in Jails
$915,611Melissa Jean Zielinski · Univ Of Arkansas For Med Scis · R61 · FY2023 · DA
ORWH: SCOR on Sex and Gender Factors Affecting Women's *
$915,538Kathleen Theresa Brady · Medical University Of South Carolina · P50 · FY2006 · DA
Optimizing methadone treatment strategies for opioid use disorder in the era of fentanyl
$915,478Francesca Beaudoin · Brown University · R01 · FY2025 · DA
An augmented reality platform to reduce post-operative and chronic opioid use in pediatric cancer
$915,421Christina York · Altality, Inc. · R42 · FY2021 · DA